SUN Pharmaceutical Industries Limited Doxorubicin Export Data — India (DGFT 2022–2026)

Name: SUN Pharmaceutical Industries Limited Doxorubicin Export Records India — #1 Exporter, 149 Shipments, $7.5M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Doxorubicin

India Pharmaceutical Trade Intelligence

$67.3M310 Suppliers136 CountriesHS 30049046

ExportsIndia → UNITED STATES39.4%India → CANADA18.9%

ImportsAUSTRALIA → India$16.6M BELGIUM → India$508.7K

#1 Supplier: SUN PHARMACEUTICAL #1 Buyer: TARO PHARMACEUTICALS

SUN Pharmaceutical Industries Limited — Doxorubicin Exporter #1 | $7.8M Trade Value | TransData Nexus | TransData Nexus

SUN Pharmaceutical Industries Limited — Doxorubicin Exporter Profile

Indian Pharmaceutical Exporter · #1 for Doxorubicin · $7.8M export value · DGFT Verified

SUN Pharmaceutical Industries Limited is the #1 Indian exporter of Doxorubicin with $7.8M in export value and 149 verified shipments. SUN Pharmaceutical Industries Limited holds a 11.1% market share in Doxorubicin exports across 15 countries. The company exports 118 pharmaceutical products worth $979.8M across 25 therapeutic categories.

SUN Pharmaceutical Industries Limited — Doxorubicin Export Profile: Buyers & Destinations

SUN Pharmaceutical Industries Limited Doxorubicin export treemap — buyers and destination countries | TransData Nexus

Where Does SUN Pharmaceutical Industries Limited Export Doxorubicin?

Country	Value	Shipments	Share
UNITED STATES	$3.3M	84	50.0%
CANADA	$750.0K	15	11.5%
MOZAMBIQUE	$451.4K	11	6.9%
AUSTRALIA	$450.0K	9

Who Are the Top Buyers of Doxorubicin from SUN Pharmaceutical Industries Limited?

Buyer	Country	Value	Orders
SUN PHARMACEUTICAL INDUSTRIES,INC.	UNITED STATES	$800.0K	17
SUN PHARMACEUTICAL INDUSTRIES INC	UNITED STATES	$628.9K	22
RXCROSSROADS 3PL LLC	UNITED STATES	$600.0K	12
SUN PHARMACEUTICAL INDUSTRIES INC.,	UNITED STATES	$550.0K	11
TARO PHARMACEUTICALS INC.	CANADA	$500.0K	10
SUN PHARMA ANZ PTY LTD	AUSTRALIA	$350.0K	7
SUN PHARMACEUTICAL BANGLADESH LTD	BANGLADESH	$350.0K	7
SUN PHARMACEUTICAL INDUSTRIESINC.	UNITED STATES	$250.0K	5
HAPHARCOJ S CBRANCH	VIETNAM	$200.0K	4
SUN PHARMACEUTICAL INDUSTRIES INC.	UNITED STATES	$150.2K	6

SUN Pharmaceutical Industries Limited supplies Doxorubicin to 38 buyers globally. The largest buyer is SUN PHARMACEUTICAL INDUSTRIES,INC. (UNITED STATES), followed by SUN PHARMACEUTICAL INDUSTRIES INC (UNITED STATES) and RXCROSSROADS 3PL LLC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Doxorubicin Formulations Does SUN Pharmaceutical Industries Limited Export?

Product Description / Formulation	Value	Shipments
DOXORUBICIN HYDROCHLORIDE LIPOSOME INJEC	$550.0K	11
TARO-DOXORUBICIN HYDROCHLORIDE LIPOSOME	$300.0K	6
DOXORUBICIN LIPO 50MG 25ML VL01 01 BAN PACK 1 VIAL SAP CODE 1157289	$150.0K	3
DOXORUBICIN LIPO 50MG 25ML VL01 01 BANPACK 1 VIAL SAP CODE 1157289	$150.0K	3
CHEMODOX 2MG/ML 10ML INJECTION DOXORUBICIN HYDROCHLORIDE LIPOSOME INJECTION 2MG/ML 10ML VIAL [PACK: 1 VIAL]	$150.0K	3
DOXORUBICIN HYDROCHLORIDE LIPOSOME, 2MG/ML, 25ML VIAL EACH VIAL CONTAINS DOXORUBICIN HYDROCHLORIDE 50MGPCS	$133.9K	3
CHEMODOX(DOXORUBICIN HYDROCHLORIDE LIPSO	$100.0K	2
DOXORUBICIN HYDROCHLORIDE LIPOSOMEINJECTION 20 MG/10 ML (2 MG/ML) (ANDA-US-FZE) (NORTHSTAR) PACK : 1 VIAL S	$100.0K	2
CHEMODOX 2MG ML 10ML INJECTION DOXORUBICIN HYDROCHLORIDE LIPOSOME PACK 1 VIAL SAP CODE 1121212	$100.0K	2
DOXORUBICIN HYDROCHLORIDE LIPOSOME 50MG/	$67.6K	3

SUN Pharmaceutical Industries Limited exports 124 distinct Doxorubicin formulations including tablets, capsules, syrups, and combination drugs. The top formulation is DOXORUBICIN HYDROCHLORIDE LIPOSOME INJEC with 11 shipments worth $550.0K.

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Doxorubicin Exporters?

Exporters ranked immediately above and below #1 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	SUN PHARMACEUTICAL INDUSTRIES LIMITED ★	$7.5M	149	15	$50.0K
3	FRESENIUS KABI ONCOLOGY LIMITED	$3.1M	143	18	$21.5K
2	DR.REDDY'S LABORATORIES LTD	$2.5M	51	11	$50.0K

SUN Pharmaceutical Industries Limited ranks #1 among 310 Indian Doxorubicin exporters. Average shipment value of $50.0K compared to the market average of $70.4K. The closest competitors by value are FRESENIUS KABI ONCOLOGY LIMITED and DR.REDDY'S LABORATORIES LTD.

Which Indian Ports Ship Doxorubicin Exports?

Port	Shipments	% Share
SAHAR AIR	639	18.3%
SAHAR AIR CARGO ACC (INBOM4)	577	16.5%
DELHI AIR CARGO ACC (INDEL4)	464	13.3%
DELHI AIR	399	11.4%
Bombay Air	188	5.4%
AHEMDABAD AIR	150	4.3%
AHEMDABAD AIR ACC (INAMD4)	120	3.4%
Delhi Air	85	2.4%

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Doxorubicin Exports

Sun Pharma's export operations, valued at $979.8 million, are significantly influenced by current geopolitical events. The ongoing Israel-Iran tensions have led to disruptions in the Red Sea shipping routes, a critical corridor for Indian pharmaceutical exports to Europe and North Africa. Major shipping lines have imposed 'Emergency Risk Surcharges,' increasing freight costs and extending transit times by 10–15 days. These delays pose risks to the integrity of time-sensitive and temperature-controlled pharmaceutical shipments. (pharmaceuticalcommerce.com)

In the United States, policy shifts towards domestic manufacturing and the imposition of tariffs on imported pharmaceuticals have created challenges for Indian exporters. Sun Pharma, which supplies a substantial portion of generics to the U.S. market, faces potential reductions in export volumes due to these protectionist measures. The company is exploring strategies such as establishing local partnerships and investing in U.S.-based manufacturing to mitigate these impacts. (odrindia.in)

The European Union's implementation of the Carbon Border Adjustment Mechanism (CBAM) introduces additional compliance requirements for exporters. Sun Pharma must adapt to these regulations to maintain its market presence in the EU, necessitating investments in sustainable manufacturing practices and comprehensive reporting mechanisms. (sgeexport.com)

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains a critical focus for Sun Pharma. The company has encountered challenges with the U.S. FDA, including import alerts and non-compliance letters for certain facilities. Addressing these issues involves implementing corrective actions and awaiting reinspection to resume full operations. (business-standard.com)

Globally, the pharmaceutical industry faces increasing scrutiny regarding quality standards. Sun Pharma's commitment to adhering to Good Manufacturing Practices (GMP) and other regulatory requirements is essential to maintain its export licenses and market reputation. Continuous investment in quality control systems and compliance infrastructure is imperative to navigate the evolving regulatory landscape.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Doxorubicin shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: SUN Pharmaceutical Industries Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 157 individual customs records matching SUN Pharmaceutical Industries Limited exporting Doxorubicin, covering 124 formulations to 18 countries via 38 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 136+ countries, 899+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Doxorubicin

Doxorubicin

SUN Pharmaceutical Industries Limited — Doxorubicin Exporter Profile

SUN Pharmaceutical Industries Limited — Doxorubicin Export Profile: Buyers & Destinations

Where Does SUN Pharmaceutical Industries Limited Export Doxorubicin?

Who Are the Top Buyers of Doxorubicin from SUN Pharmaceutical Industries Limited?

What Is India's Total Doxorubicin Export Value and How Much Does SUN Pharmaceutical Industries Limited Contribute?

What Is the Average Shipment Value for SUN Pharmaceutical Industries Limited's Doxorubicin Exports?

How Does SUN Pharmaceutical Industries Limited Compare to Other Indian Doxorubicin Exporters?

What Doxorubicin Formulations Does SUN Pharmaceutical Industries Limited Export?

Regulatory Requirements: Exporting Doxorubicin to Key Markets

United States — FDA

Canada — HC

How Does SUN Pharmaceutical Industries Limited Compare to Nearest Doxorubicin Exporters?

Which Indian Ports Ship Doxorubicin Exports?

Geopolitical & Trade Policy Impact on SUN Pharmaceutical Industries Limited's Doxorubicin Exports

SUN Pharmaceutical Industries Limited — Regulatory Compliance & Quality Standards

About SUN Pharmaceutical Industries Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Doxorubicin Export Data from SUN Pharmaceutical Industries Limited

Doxorubicin Stats

Company Overview

Top Products by SUN Pharmaceutical Industries Limited

Related Analysis

Need Detailed Export Data?

Data Source